BD is issuing a notification to inform customers that Cardinal Health branded Monoject™ syringes have not been validated for use with the BD Alaris™ infusion devices. BD has validated Covidien branded Monoject™ syringes for use with the BD Alaris™ infusion devices. Cardinal Health, rebranded its syringes from Covidien Monoject™ to Cardinal Health Monoject™ and retained the original Covidien SKU numbers. BD's investigation determined that there may differences in syringe dimensions associated with these changes that may impact BD Alaris infusion devices. Recall start date: October 12, 2023